8 / 9
Note:
Page 20
May 22-23, 2019 | Rome, Italy
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
alliedacademies.comYEARS
IMMUNOLOGY
AND CANCER THERAPY
2
nd
Global Summit on
Immunotherapy 2019
Immunology Case Reports | Volume 3
Wassil Nowicky is the Director of Nowicky Pharma and President of the Ukrainian Anti-Cancer Institute, Austria. He is the Inventor
of the anti-cancer preparation on the basis of celandine alkaloids “NSC-631570”. He is the author of over 300 scientific articles ded-
icated to cancer research. He is a real member of the New York Academy of Sciences, member of the European Union for applied
immunology and of the American Association for scientific progress. He is the Honorary Doctor of the Yanka Kupala State University
in Grodno, Doctor Honoris Causa of the Open International University on Complex Medicine in Colombo, Honorary Member of the
Austrian Society. He has received the award for Merits of National Guild of Pharmacists of America, the award of Austrian Society of
Sanitary, Hygiene and Public Health Services and others.
dr.nowicky@yahoo.deBIOGRAPHY
Conclusion:
Thus, NSC-631570 exhibits powerful therapeutic effect in the treatment of malignant melanoma.
The drug not only selectively kills tumor cells but also recovers the role of the dying primary tumor as an effec-
tive immunogenic hub.
Recent Publications:
1.
Funel N, Costa F, Pettinari L, Taddeo A, Sala A, Chiriva-Internati M and Dalle-Donne I (2010) Ukrain
affects pancreas cancer cell phenotype
in vitro
by targeting MMP-9 and intra-/extracellular SPARC ex-
pression. Pancreatology, 10(5): 545-552.
2.
M Skivka L, G Fedorchuk O, M Susak Y, Y Susak M, M Malanchuk O, P Rudyk M and Nowicky W (2015)
Physical activity interferes with the immunomodulatory effect of the antineoplastic drug NSC631570.
Current pharmaceutical biotechnology 16(1): 49-59.
3.
Rudyk M, Fedorchuk O, Susak Y, Nowicky Y and Skivka L (2016) Introduction of antineoplastic drug
NSC631570 in an inpatient and outpatient setting: Comparative evaluation of biological effects. Asian
Journal of Pharmaceutical Sciences 11(2): 308-317.
4.
Jesionek W, Fornal E, Majer-Dziedzic B, Móricz Á M, Nowicky W and Choma I M (2016) Investigation of
the composition and antibacterial activity of Ukrain™ drug using liquid chromatography techniques.
Journal of Chromatography A 1429: 340-347.